Investor profile

Connecticut Innovations logo

Connecticut Innovations

USAI/MLDeep TechClimateHealthtechBio/PharmaB2B SaaSFintechCybersecurityEnterpriseOther

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

Connecticut Innovations (CI) is Connecticut's strategic venture capital arm and the leading source of financing and ongoing support for innovative, growing companies in the state. CI actively seeks proof-of-concept, pre-seed, seed, and early-stage investments with a focus on biosciences, technology, and climate verticals, typically investing between $100,000 and $1.5 million per round, with larger commitments available through dedicated funds. By offering equity and debt investments, strategic guidance, and introductions to valuable partners, CI enables promising businesses to thrive across all stages of growth. CI deploys capital through several thematic funds: the $50M AI/Q Fund targeting scalable commercial AI, quantum computing, and deep tech ventures; the $100M ClimateTech Fund supporting early-stage and growth climate companies; the $200M Connecticut Bioscience Innovation Fund; and the $50M Future Fund focused on diverse ideas and industries. CI leads approximately 70% of first investments in Connecticut startups, supporting nascent companies as they build proof of concept, and partners with entrepreneurs, venture capital firms, universities, corporate innovation arms, and government organizations to grow Connecticut's innovation ecosystem.

Notable quotes

Connecticut Innovations is one of the most active early-stage investors in the United States, and it has a reputation for having an experienced team that thoroughly analyzes its deals and provides strategic guidance.

Matthew McCooe · Hartford Business Journal – 'Matt McCooe is CI's new CEO' · 2015

CI began the new fiscal year with steady deal activity and strong participation across key sectors like healthcare, climate tech and AI.

Peter Longo · PRWeb – 'Connecticut Innovations Invests $11.3 Million in Early-Stage Companies in Q1 FY26' · 2025-11-03

Healthcare continues to be one of CI's largest areas of investment.

Matthew Storeygard · PRWeb – 'Connecticut Innovations Invests $7.4 Million in Early-Stage Companies in Q3 FY25' · 2025-04-23

Team

Matthew McCooe

Chief Executive Officer

AI/MLDeep TechB2B SaaSHealthtechClimate

Peter Longo

Senior Managing Director, Investments

AI/MLHealthtechClimateEnterprise

Matthew Storeygard

Senior Managing Director, Investments & Bio Team Director

HealthtechBio/PharmaAI/ML

Kevin Crowley

Senior Managing Director, Investments

HealthtechBio/PharmaEnterprise

Alison Malloy

Managing Director, Investments

CybersecurityAI/MLEnterprise

Gwen Cheni

Director, AI/Q Fund

AI/MLDeep Tech

Recent investments

CompanyRoundSizeDate
CloudSEKSeries B2$10m2026-01
CoinbaxSeed$4m2025-12
Inbox HealthSeries B$20m2025-09
Bloom CreditGrowth$11m2025-04
PHYNDSeed$10m2025-02
Alexion PharmaceuticalsEarly Stage
Biohaven PharmaceuticalEarly Stage
VeraDermicsIPO Exit$256m2026-02
BudderflyGrowth
Driver TechnologiesEarly Stage

Frequent co-investors

Fit check

Is Connecticut Innovations a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit